There is no approved product, no approved dosing schedule, and no standard pharmacy supply chain
However, if you plan to use appetite suppressants like phentermine (Schedule IV) or any off-label stimulants, youll need either: Plan your service model accordingly
According to the websites of these drugs, there are warnings that there may be dose-dependent and treatment duration-dependent risk for C cell tumors at clinically relevant exposures. This has not been studied in humans and, thus far, there are no reports of these findings
Medication reconciliation should specifically include inquiry regarding the use of semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide, and related agents, as patients may not recognize these medications as relevant to anesthesia planning